X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 65 filers reported holding X4 PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,417 | -12.4% | 1,628,980 | 0.0% | 0.09% | -13.9% |
| Q4 2022 | $1,618 | -99.9% | 1,628,980 | +96.1% | 0.11% | +9.1% |
| Q3 2022 | $1,420,000 | +1320.0% | 830,654 | +698.9% | 0.10% | +1137.5% |
| Q2 2022 | $100,000 | -45.1% | 103,980 | 0.0% | 0.01% | -42.9% |
| Q1 2022 | $182,000 | -23.5% | 103,980 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $238,000 | -56.7% | 103,980 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $550,000 | -18.6% | 103,980 | 0.0% | 0.02% | -4.3% |
| Q2 2021 | $676,000 | -24.5% | 103,980 | 0.0% | 0.02% | +15.0% |
| Q1 2021 | $895,000 | +33.8% | 103,980 | 0.0% | 0.02% | +25.0% |
| Q4 2020 | $669,000 | -61.9% | 103,980 | -68.4% | 0.02% | -76.1% |
| Q2 2020 | $1,757,000 | -48.6% | 328,980 | -3.7% | 0.07% | -57.9% |
| Q1 2020 | $3,416,000 | +26.3% | 341,618 | +35.2% | 0.16% | +47.2% |
| Q4 2019 | $2,704,000 | -75.9% | 252,747 | -71.3% | 0.11% | -84.2% |
| Q3 2019 | $11,206,000 | -16.1% | 881,681 | -1.0% | 0.68% | -11.1% |
| Q2 2019 | $13,356,000 | +203.5% | 890,387 | +252.3% | 0.77% | +158.2% |
| Q1 2019 | $4,400,000 | – | 252,749 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |